tiprankstipranks

Andrew Blight Insider Profile

4 Followers
Andrew Blight, CSO at Acorda Therapeutics, holds 71.66K shares in Acorda Therapeutics (Ticker: ACORQ).
tipranks
Andrew Blight

Andrew Blight
Acorda Therapeutics (ACORQ)
CSO

Not Ranked
Andrew Blight has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$63K
100.00%
A breakdown of Andrew Blight's holdings

Insider Roles

Acorda Therapeutics
(ACORQ)
CSO
Roles that Andrew Blight holds in companies

Most Profitable Insider Trade

Stock:
Acorda Therapeutics
(ACORQ)
Rating:Informative Buy
Date:Aug 11, 2016 - Aug 11, 2017
Return:-11.10%
The most profitable trade made by Andrew Blight

Andrew Blight's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Acorda Therapeutics
Mar 03, 2017
CSO
Uninformative Buy
$62.99K
Success Rate for
ACORQ
0 out of 1 profitable transactions on
ACORQ
0%
Average Return for
ACORQ
Average return per transaction on
ACORQ
-11.10%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 07, 2014
Uninformative Buy
$0.00
-
$0.00
Mar 08, 2013
Uninformative Buy
$0.00
-
$0.00
Mar 19, 2012
Uninformative Buy
$0.00
-
$0.00
Mar 07, 2011
Uninformative Buy
$0.00
-
$0.00
Apr 02, 2010
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Andrew Blight's performance on stock

Andrew Blight insider profile FAQ

What is the percentage of profitable transactions made by Andrew Blight?
The percentage of profitable transactions made by Andrew Blight is ―.
    What is the average return per transaction made by Andrew Blight?
    The average return per transaction made by Andrew Blight is ―.
      What stocks does Andrew Blight hold?
      Andrew Blight holds: ACORQ stocks.
        What was Andrew Blight’s latest transaction?
        Andrew Blight latest transaction was an Uninformative Buy of ―.
          What was Andrew Blight's most profitable transaction?
          Andrew Blight’s most profitable transaction was an Informative Buy of ACORQ stock on August 11, 2016. The return on the trade was -11.10%.
            What is Andrew Blight's role in Acorda Therapeutics?
            Andrew Blight's role in Acorda Therapeutics is CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.